Trial Profile
A phase II efficacy study of IPP 204106 in the treatment of patients with cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2012
Price :
$35
*
At a glance
- Drugs IPP 204106 (Primary)
- Indications Cancer
- Focus Biomarker; Therapeutic Use
- 10 Oct 2012 New trial record